igeahub.com
Study Reveals that Opdivo from Bristol-Myers extends survival in head and neck cancer - IgeaHub
Apr 19, 2016 According to data from a late-stage study, the cancer immunotherapy drug of Bristol-Myers Squibb, Opdivo, assisted advanced head and neck